Harley Kurata

Professor University of Alberta

Seminars

Wednesday 23rd September 2026
Lipid-dependence of Kv7 Activator Drugs: Insights for Selective & Effective Potassium Channel Therapeutics
9:45 am
  • Defining how Kv7 activators modulate voltage-gated potassium channels to improve mechanistic understanding of ion channel pharmacology
  • Revealing how membrane lipid composition influences drug activity, specificity, and channel regulation across Kv7 subtypes
  • Applying molecular-level insights to understand selectivity, potency, and efficacy of potassium channel targeted therapeutics for epilepsy and pain disorders
Harley Kurata- speaker for Ion Channel-Targeted Drug Development Summit